ArticleCell reports. Medicine2022

SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancer.

Meghan A Rice et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.